Navigation Links
USC and Coulter Foundation Partner to Invest $5M in Breakthrough Innovation in Biomedical Engineering
Date:4/26/2011

tend, and improve patient lives. The Foundation's broad mandate addresses suffering from any disease or condition, in any size market, in any discipline, in any country around the world.

"This award is a testament to the national leadership of our Biomedical Engineering Department in Translational Biomedical Engineering Research," said Yannis C. Yortsos, Dean of the USC Viterbi School of Engineering. "The Program will contribute to solving pressing societal health issues. It also fits well with the strategic plan of our BME Department, the Viterbi School of Engineering and complements the University's vision to support interdisciplinary and translational research."

Dr. Norberto Grzywacz, Professor and Chair of the Viterbi School's Department of BME led the collaborative effort as its principal investigator (PI).  The co-PIs were Thomas A. Buchanan, M.D., Professor of Medicine, Obstetrics and Gynecology, Associate Dean of Clinical Research at the Keck School of Medicine, and Director of the CTSI, and Krisztina "Z" Holly, Vice Provost for Innovation and Executive Director of the USC Stevens Institute for Innovation. The team also included Dr. Richard Hull, Senior Director for New Ventures and Alliances at the USC Stevens Institute for Innovation.

"This program harnesses critical gap funding, expertise, and focus to move USC's breakthrough biomedical engineering ideas into positive societal impact," said Holly. "We are thrilled to be working with the Coulter Foundation; this partnership is a key new piece of our interdisciplinary approach to innovation here at USC."

Co-PI Buchanan adds, "This is an outstanding opportunity to create the new interdisciplinary research teams to develop new approaches to diagnose and treat human disease. CTSI was designed to do just that. We are both proud and excited to be part of the USC partnership that won this prestigious award."

The first co-Directors of the Program are Mr. Juan Felipe Va
'/>"/>

SOURCE USC Stevens Institute for Innovation; USC Viterbi School of Engineering
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
2. Beckman Coulter to Present at the Morgan Stanley Healthcare Unplugged Conference
3. Beckman Coulter Investor Events Second Half of 2008
4. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
5. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
6. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
7. Beckman Coulter to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
8. Beckman Coulter to Present at Upcoming Healthcare Conferences
9. Beckman Coulter to Host Annual Business Review
10. Beckman Coulter to Present at the 27th Annual J.P. Morgan Healthcare Conference
11. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... July 1, 2015  Axovant Sciences Ltd. (NYSE: ... the treatment of dementia, today announced that the ... 22 at 5:45 p.m. EDT following its presentation ... International Conference 2015 (AAIC). The ... , Dr. Lawrence Friedhoff , Chief Development ...
(Date:7/1/2015)... IN (PRWEB) , ... July 01, 2015 , ... Apex ... 2015 BIO International Convention in Philadelphia, PA. , The presentation took place ... and outlined the plans for the development of APX3330 for the treatment of pancreatic ...
(Date:6/30/2015)... ... June 30, 2015 , ... Students ... part in the first half of “Integrative Biotechnology,” an applied biotechnology course team-taught ... summer 2014, this course combines students from both universities and is taught on ...
(Date:6/30/2015)...  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ), a ... address unmet medical needs in women,s health, today ... present at the Cantor Fitzgerald Inaugural Healthcare Conference ... 4:45 PM EDTLocation: , Le Parker Meridien Hotel, ... www.juniperpharma.com, under  ,Investor, or  click here ...
Breaking Biology Technology:Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2
... , , ROCKVILLE, Md. , ... of the PARADIGM trial, a Phase 2 clinical study ... of individuals with suspected central nervous system infection due ... held biotechnology company that develops immunotherapeutics to treat autoimmune ...
... SYDNEY, July 12 /PRNewswire-Asia/ -- Pharmaxis (ASX: ... to voluntarily de-list from the Nasdaq Global,Market ("Nasdaq"). , ... review of the demand from existing and,potential international investors ... on Nasdaq and the volume of Pharmaxis ADS trading,in ...
... ,PROVIDENCE, R.I. [Brown University] Rashid Zia, assistant professor ... winners of the Presidential Early Career Awards for Scientists ... of winners this week. The PECASE award recognizes ... show exceptional potential for leadership at the frontiers of ...
Cached Biology Technology:MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus 2MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus 3MacroGenics Announces the Initiation of a Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Monoclonal Antibody MGAWN1 in Subjects with Suspected Central Nervous System Infection Due to West Nile Virus 4Pharmaxis to Voluntarily De-List from Nasdaq 2Brown engineering professor wins prestigious White House award 2
(Date:6/23/2015)... , June 23, 2015   MedNet ... that supports the entire spectrum of clinical research, ... ™ , the company,s intuitive, flexible ... awarded a Silver 2015 Stevie® Award by the ... Products & Services Website category.  The American Business ...
(Date:6/18/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market announces that its Wocket® smart wallet will be ... Mark", scheduled to air on WABC Radio (am770) in ... The broadcast air- time for the extensive ... NXT-ID, Inc.,s CEO Gino Pereira will be discussing ...
(Date:6/16/2015)... QUEBEC CITY , June 16, 2015 /CNW ... announce their partnership centralized around the incorporation of ... mobile point-of-care diagnostic laboratory, the Mo-POD™. This unprecedented ... the BIO International Conference at the ... from June 15 th to ...
Breaking Biology News(10 mins):MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3
... The largest genome-wide association study ever conducted on ... has identified 16 new genetic associations related to ... 23andMe, the leading personal genetics company, and the ... examined data for more than 53,000 individuals. The ...
... who give birth vaginally are at increased risk of developing ... a study of Chinese women by researchers at Yale School ... online July 1 in the British Journal of Obstetrics ... labor and delivery made the pelvic floor relax and not ...
... that the key to treating neurodegenerative prion diseases such ... in the ribosome, the protein synthesis machinery of the ... Journal of Biological Chemistry . Prion diseases are ... Examples of prion diseases are scrapie in sheep, mad ...
Cached Biology News:23andMe and ALSPAC identify 16 new genetic associations for pollen, dust-mite and cat allergies 223andMe and ALSPAC identify 16 new genetic associations for pollen, dust-mite and cat allergies 3Vaginal delivery ups risk of pelvic organ prolapse 2The ribosome -- a new target for antiprion medicines 2
... (Human Exonic Evidence Based Oligonucleotide) Genome Set ... ) Genome Set contain a collection of ... constitutively expressed exons, allowing interrogation of thousands ... researchers at Stanford University and UCSF, the ...
odz, odd Oz/ten-m homolog 1 [Source:RefSeq_peptide;Acc:NP_055068] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Rabbit polyclonal to FANCE ( Abpromise for all tested applications). entrezGeneID: 2178 SwissProtID: Q9HB96...
Rabbit polyclonal to NIRF ( Abpromise for all tested applications). Antigen: Synthetic peptide derived from residues 186-235 of human NIRF. Entrez Gene ID: 115426 Swiss Protein ID: Q96PU...
Biology Products: